News
Click here for news in Danish.
December 30, 2010 | Company Announcements
Total number of voting rights and share capital in Bavarian Nordic A/SDecember 16, 2010 | Company Announcements
Bavarian Nordic awards warrants to certain employeesDecember 08, 2010 | Company Announcements
Bavarian Nordic Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Trial of PROSTVAC®December 06, 2010 | Company Announcements
Bavarian Nordic A/S – Major Shareholder AnnouncementDecember 06, 2010 | Company Announcements
Bavarian Nordic A/S completes registration of share capital increase and upgrades its expectations to year-end cash preparednessNovember 30, 2010 | Company Announcements
Bavarian Nordic A/S completes a private placement at market priceNovember 30, 2010 | Company Announcements
Bavarian Nordic A/S launches a private placement at market priceNovember 09, 2010 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 September 2010October 13, 2010 | Company Announcements
Bavarian Nordic Receives NIH Grant to Investigate the Potential of an MVA-BN® based Vaccine against Ebola and Marburg VirusesOctober 12, 2010 | Company Announcements
US Government Exercises Next Part of Bavarian Nordic’s Freeze-Dried IMVAMUNE® ContractOctober 05, 2010 | Company Announcements
Bavarian Nordic’s MVA-BN® patent stands in European validity challengeSeptember 30, 2010 | Company Announcements
Bavarian Nordic Realigns for ExpansionSeptember 15, 2010 | Company Announcements
Bavarian Nordic issues Financial Calendar for 2011August 31, 2010 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 30 June 2010August 19, 2010 | Press Releases
Bavarian Nordic Responds to HHS Review of Strategy for Medical CountermeasuresJuly 13, 2010 | Press Releases
Bavarian Nordic Delivers 1 Million Doses of First Vaccine Developed Under U.S. Biopreparedness Program to the Strategic National StockpileMay 25, 2010 | Company Announcements
Bavarian Nordic awards warrants to management and certain employeesMay 25, 2010 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held 25 May 2010May 21, 2010 | Company Announcements
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with suchMay 17, 2010 | Company Announcements
Bavarian Nordic Begins Delivery of IMVAMUNE® to the U.S. Strategic National StockpileApril 29, 2010 | Company Announcements
Bavarian Nordic A/S – Notice convening extraordinary general meetingApril 29, 2010 | Company Announcements
Bavarian Nordic Receives FDA Fast Track Designation for PROSTVAC™April 27, 2010 | Company Announcements
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held 27 April 2010April 27, 2010 | Company Announcements
Bavarian Nordic A/S – Interim Report for the period 1 January to 31 March 2010March 30, 2010 | Company Announcements
Bavarian Nordic A/S – Notice convening ordinary general meeting